Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related SEMG
Mid-Afternoon Market Update: Mattel Jumps Following Report of Approach from Hasbro; Viewray Shares Drop
Mid-Morning Market Update: Markets Edge Lower; Tyson Foods Tops Q4 Expectations
Related TBPH
30 Biggest Movers From Yesterday
33 Stocks Moving In Wednesday's Mid-Day Session

 

  • Analysts at Piper Jaffray initiated coverage on Theravance Biopharma Inc (NASDAQ: TBPH) with an Overweight rating. The price target for Theravance Biopharma is set to $42. Theravance Biopharma shares closed at $25.10 on Wednesday.
  • B. Riley initiated coverage on Viveve Medical Inc (NASDAQ: VIVE) with a Buy rating. The price target for Viveve Medical is set to $8. Viveve Medical shares closed at $4.45 on Wednesday.
  • Analysts at Deutsche Bank initiated coverage of Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) with a Buy rating. Alexion Pharmaceuticals shares closed at $127.74 on Wednesday.
  • Analysts at Citigroup assumed coverage of SemGroup Corp (NYSE: SEMG) with a Neutral rating. The price target for SemGroup is set to $34. SemGroup shares closed at $30.35 on Wednesday.
  • Analysts at Deutsche Bank initiated coverage on Halozyme Therapeutics, Inc. (NASDAQ: HALO) with a Buy rating. Halozyme Therapeutics shares closed at $8.32 on Wednesday.
  • Analysts at Aegis Capital initiated coverage on Cynosure, Inc. (NASDAQ: CYNO) with a Buy rating. The price target for Cynosure is set to $60. Cynosure shares closed at $41.00 on Wednesday.
  • Analysts at Credit Suisse assumed coverage on Sunrun Inc (NASDAQ: RUN) with an Outperform rating. The price target for Sunrun is set to $18. Sunrun shares closed at $4.63 on Wednesday.
  • Analysts at Deutsche Bank initiated coverage on Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) with a Hold rating. The price target for Ariad Pharmaceuticals is set to $9.50. Ariad Pharmaceuticals shares closed at $9.01 on Wednesday.

Latest Ratings for SEMG

DateFirmActionFromTo
Jan 2018U.S. Capital AdvisorsDowngradesOverweightHold
Nov 2017Morgan StanleyMaintainsEqual-Weight
Nov 2017UBSMaintainsBuy

View More Analyst Ratings for SEMG
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (ALXN + ARIA)

View Comments and Join the Discussion!